U.S. flag

An official website of the United States government

NM_000051.4(ATM):c.5712dup (p.Ser1905fs) AND Malignant tumor of breast

Germline classification:
Pathogenic (1 submission)
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001355219.5

Allele description [Variation Report for NM_000051.4(ATM):c.5712dup (p.Ser1905fs)]

NM_000051.4(ATM):c.5712dup (p.Ser1905fs)

Gene:
ATM:ATM serine/threonine kinase [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
11q22.3
Genomic location:
Preferred name:
NM_000051.4(ATM):c.5712dup (p.Ser1905fs)
HGVS:
  • NC_000011.10:g.108307934dup
  • NG_009830.1:g.90103dup
  • NG_054724.1:g.166904dup
  • NM_000051.4:c.5712dupMANE SELECT
  • NM_001351834.2:c.5712dup
  • NP_000042.3:p.Ser1905fs
  • NP_000042.3:p.Ser1905fs
  • NP_001338763.1:p.Ser1905fs
  • LRG_135t1:c.5712dup
  • LRG_135:g.90103dup
  • LRG_135p1:p.Ser1905fs
  • NC_000011.9:g.108178655_108178656insA
  • NC_000011.9:g.108178661dup
  • NM_000051.3:c.5712dup
  • NM_000051.3:c.5712dupA
  • NM_000051.4:c.5712dupAMANE SELECT
  • p.S1905Ifs*25
  • p.S1905IfsX25
Protein change:
S1905fs
Links:
dbSNP: rs587781730
NCBI 1000 Genomes Browser:
rs587781730
Molecular consequence:
  • NM_000051.4:c.5712dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001351834.2:c.5712dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Malignant tumor of breast
Synonyms:
Malignant breast neoplasm; Cancer breast
Identifiers:
MONDO: MONDO:0007254; MedGen: C0006142

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001550039Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR)

See additional submitters

no assertion criteria provided
Pathogenicunknownclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR), SCV001550039.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The ATM p.Ser1905Ilefs*25 variant was identified in 9 of 20562 proband chromosomes (frequency: 0.0004) from individuals or families with Ataxia-Telangiectasia or pancreatic cancer (Becker-Catania 2000, Li 2000, Mitui 2005, Susswein 2015). The variant was also identified in dbSNP (ID: rs1040777064), ClinVar (classified as pathogenic by Invitae, Ambry Genetics, GeneDx, Color and Mendelics Analise Genomica; and as likely pathogenic by Counsyl). The variant was not identified in LOVD 3.0. The variant was not identified in the following databases: the Exome Aggregation Consortium (August 8th 2016) or the Genome Aggregation Database (Feb 27, 2017). The c.5712dup variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at codon 1905 and leads to a premature stop codon at position 1929. This alteration is then predicted to result in a truncated or absent protein and loss of function. Loss of function variants of the ATM gene are an established mechanism of disease in ATM associated cancers and is the type of variant expected to cause the disorder. In summary, based on the above information, this variant meets our laboratory’s criteria to be classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 20, 2024